Table 2.
Coronary angiographic findings in the three study groups.
| Variable | Rosuvastatin (n = 33) | Atorvastatin (n = 33) | Control (n = 33) | p-Value |
|---|---|---|---|---|
| Culprit lesion | 0.660 † | |||
| RCA, n (%) | 8 (24.2%) | 10 (30.3%) | 5 (15.2%) | |
| LAD, n (%) | 23 (69.7%) | 22 (66.7%) | 26 (78.8%) | |
| LCX, n (%) | 2 (6.1%) | 1 (3.0%) | 2 (6.1%) | |
| TIMI before PCI | 0.906 ‡ | |||
| TIMI 0, n (%) | 27 (81.8%) | 22 (66.7%) | 28 (84.8%) | |
| TIMI I, n (%) | 2 (6.1%) | 1 (3.0%) | 0 (0.0%) | |
| TIMI II, n (%) | 2 (6.1%) | 2 (6.1%) | 4 (12.1%) | |
| TIMI III, n (%) | 2 (6.1%) | 8 (24.2%) | 1 (3.0%) |
n = number. RCA = right coronary artery. LAD = left anterior descending. LCX = left circumflex. TIMI = thrombolysis in myocardial infarction. † Fisher’s exact test. ‡ Chi-square test for trend.